Return to Article Details
Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma
Download
Download PDF
https://mail.cellmolbiol.org/index.php/CMB
Themes by Openjournaltheme.com
Themes by Openjournaltheme.com